Addyi was initial approved via the FDA in August 2015 to deal with hypoactive sexual need condition (HSDD) in premenopausal women. Which is just yet another way of claiming it boosts sex push (also called libido) in women which have not achieved menopause. It was the main these drug accepted https://snoopa962ghh9.webdesign96.com/profile